1. Home
  2. BVS vs GMRE Comparison

BVS vs GMRE Comparison

Compare BVS & GMRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BVS
  • GMRE
  • Stock Information
  • Founded
  • BVS 2011
  • GMRE 2011
  • Country
  • BVS United States
  • GMRE United States
  • Employees
  • BVS N/A
  • GMRE N/A
  • Industry
  • BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • GMRE Real Estate Investment Trusts
  • Sector
  • BVS Health Care
  • GMRE Real Estate
  • Exchange
  • BVS Nasdaq
  • GMRE Nasdaq
  • Market Cap
  • BVS 476.3M
  • GMRE 428.4M
  • IPO Year
  • BVS 2021
  • GMRE N/A
  • Fundamental
  • Price
  • BVS $6.56
  • GMRE $30.56
  • Analyst Decision
  • BVS Strong Buy
  • GMRE Buy
  • Analyst Count
  • BVS 4
  • GMRE 2
  • Target Price
  • BVS $13.75
  • GMRE $42.50
  • AVG Volume (30 Days)
  • BVS 210.8K
  • GMRE 201.3K
  • Earning Date
  • BVS 11-04-2025
  • GMRE 11-04-2025
  • Dividend Yield
  • BVS N/A
  • GMRE 9.85%
  • EPS Growth
  • BVS N/A
  • GMRE N/A
  • EPS
  • BVS 0.03
  • GMRE 0.34
  • Revenue
  • BVS $564,142,000.00
  • GMRE $141,896,000.00
  • Revenue This Year
  • BVS N/A
  • GMRE $8.69
  • Revenue Next Year
  • BVS $7.22
  • GMRE $5.10
  • P/E Ratio
  • BVS $236.89
  • GMRE $90.79
  • Revenue Growth
  • BVS 5.08
  • GMRE 2.95
  • 52 Week Low
  • BVS $5.81
  • GMRE $30.09
  • 52 Week High
  • BVS $14.38
  • GMRE $47.00
  • Technical
  • Relative Strength Index (RSI)
  • BVS 42.70
  • GMRE 59.06
  • Support Level
  • BVS $6.66
  • GMRE $30.73
  • Resistance Level
  • BVS $7.15
  • GMRE $31.46
  • Average True Range (ATR)
  • BVS 0.27
  • GMRE 0.76
  • MACD
  • BVS -0.03
  • GMRE -0.86
  • Stochastic Oscillator
  • BVS 6.52
  • GMRE 16.67

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

About GMRE Global Medical REIT Inc.

Global Medical REIT Inc is engaged predominantly in the acquisition of purpose-built healthcare facilities and the leasing of those facilities to physician groups and regional and national healthcare systems. The company's principal business objective is to provide attractive, risk-adjusted returns to its stockholders through a combination of reliable dividends and long-term capital appreciation. Its healthcare facilities are located in secondary markets and suburbs of primary markets and are typically leased to single-tenants under triple-net leases.

Share on Social Networks: